148 related articles for article (PubMed ID: 37196069)
1. Hypofractionated Stereotactic Re-irradiation and
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel D; Ken S; Gouaze-Andersson V; Piram L; Mervoyer A; Larrieu-Ciron D; Cabarrou B; Lusque A; Robert M; Frenel JS; Uro-Coste E; Olivier P; Mounier M; Sabatini U; Sanchez EH; Zouitine M; Berjaoui A; Cohen-Jonathan Moyal E
Oncologist; 2023 Sep; 28(9):825-e817. PubMed ID: 37196069
[TBL] [Abstract][Full Text] [Related]
2. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
[TBL] [Abstract][Full Text] [Related]
4. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Sahebjam S; Forsyth PA; Tran ND; Arrington JA; Macaulay R; Etame AB; Walko CM; Boyle T; Peguero EN; Jaglal M; Mokhtari S; Enderling H; Raghunand N; Gatewood T; Long W; Dzierzeski JL; Evernden B; Robinson T; Wicklund MC; Kim S; Thompson ZJ; Chen DT; Chinnaiyan P; Yu HM
Neuro Oncol; 2021 Apr; 23(4):677-686. PubMed ID: 33173935
[TBL] [Abstract][Full Text] [Related]
6. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
[TBL] [Abstract][Full Text] [Related]
9. Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
Zwirner K; Paulsen F; Schittenhelm J; Borchers C; Skardelly M; Zips D; Eckert F
Acta Neurol Scand; 2017 Sep; 136(3):239-245. PubMed ID: 28025828
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis.
Luo T; Feng J; Sun P
Clin Neurol Neurosurg; 2023 Jun; 229():107728. PubMed ID: 37105068
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
Klobukowski L; Falkov A; Chelimo C; Fogh SE
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
[TBL] [Abstract][Full Text] [Related]
18. A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases.
Bi N; Ma Y; Xiao J; Zhang H; Xu Y; Tian Y; Li J; Zhang Y; Liu Q; Wang K; Deng L; Wang W; Chen X; Liu F; Zhao R; Yang S; Huang X; Yi J; Hu C; Li Y
Oncologist; 2019 Sep; 24(9):e914-e920. PubMed ID: 30996008
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
